Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Zhengzhou University, Henan, China.
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Skin Res Technol. 2024 Aug;30(8):e13918. doi: 10.1111/srt.13918.
Full-thickness skin grafts are widely used in plastic and reconstructive surgery. The main limitation of skin grafting is the poor textural durability and associated contracture, which often needs further corrective surgery. Excessive inflammation is the main reason for skin graft contractions, which involve overactivation of myofibroblasts. These problems have prompted the development of new therapeutic approaches, including macrophage polarization modulation and stem cell-based therapies. Currently, adipose-derived stem cells (ASCs) have shown promise in promoting skin grafts survival and regulating macrophage phenotypes. However, the roles of ASCs on macrophages in decreasing skin grafts contraction remain unknown.
Rat adipose-derived stem cells (rASCs) were isolated from rat inguinal adipose tissues. Full-thickness skin graft model was constructed on male rats divided into control group and rASCs treatment group. Skin graft was assessed for concentration, elasticity modulus and stiffness. Rat bone marrow-derived macrophages (rBMDMs) were isolated from rat femurs, and subsequent RT-qPCR and coculture assays were carried out to explore the cellular mechanisms. Immunohistochemical and immunofluorescence staining were used to verify mechanisms in vivo.
In vivo results showed that after injection of ASCs, improved texture, increased survival and inhibited contraction of skin grafts were seen. Vascularization was also improved as illustrated by laser perfusion image and vascular endothelial growth factor (VEGF) concentration. Histological analysis revealed that ASCs injection significantly reduced expression of pro-inflammatory cytokines (TNF-a, IL-1β) and increased expression of anti-inflammatory (IL-10) and pro-healing cytokines (IGF-1). At cellular level, after co-culturing with rASCs, rat bone marrow derived macrophages (rBMDMs) favored M2 polarization even under inflammatory stimulus.
ASCs treatment enhanced vascularization via angiogenic cytokines secretion and alleviated inflammatory environment in skin grafts by driving M2 macrophages polarization, which improved survival and decreased skin grafts contraction. Our work showed that ASCs transplantation can be harnessed to enhance therapeutic efficacy of skin grafting in cutaneous defects treatment.
全厚皮片移植广泛应用于整形和重建外科。皮片移植的主要局限性在于质地耐久性差和相关的挛缩,这往往需要进一步的矫正手术。过度的炎症是皮片挛缩的主要原因,涉及肌成纤维细胞的过度激活。这些问题促使人们开发新的治疗方法,包括巨噬细胞极化调节和基于干细胞的治疗。目前,脂肪来源的干细胞(ASCs)已显示出在促进皮片存活和调节巨噬细胞表型方面的潜力。然而,ASCs 对减少皮片挛缩的巨噬细胞的作用仍不清楚。
从雄性大鼠腹股沟脂肪组织中分离大鼠脂肪来源的干细胞(rASCs)。构建大鼠全厚皮片移植模型,分为对照组和 rASCs 治疗组。评估皮片的浓度、弹性模量和硬度。从大鼠股骨中分离大鼠骨髓来源的巨噬细胞(rBMDMs),并进行随后的 RT-qPCR 和共培养实验,以探讨细胞机制。免疫组织化学和免疫荧光染色用于体内验证机制。
体内结果表明,注射 ASCs 后,皮片的质地得到改善,存活率提高,挛缩得到抑制。如激光灌注图像和血管内皮生长因子(VEGF)浓度所示,血管化也得到了改善。组织学分析显示,ASCs 注射显著降低了促炎细胞因子(TNF-a、IL-1β)的表达,增加了抗炎(IL-10)和促愈细胞因子(IGF-1)的表达。在细胞水平上,与 rASCs 共培养后,即使在炎症刺激下,大鼠骨髓来源的巨噬细胞(rBMDMs)也倾向于 M2 极化。
ASCs 治疗通过分泌血管生成细胞因子增强血管生成,并通过驱动 M2 巨噬细胞极化减轻皮片移植中的炎症环境,从而提高存活率并减少皮片挛缩。我们的工作表明,ASCs 移植可以用于增强皮肤缺损治疗中皮片移植的治疗效果。